Inari Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	39.21	60.22	92.75	114.62	24.03	21.88
Short-Term Investments	76.86	266.18	83.35	49.98	0	0
Cash & Cash Equivalents	116.06	326.4	176.1	164.6	24.03	21.88
Cash Growth	-64.44%	85.35%	6.99%	585.05%	9.79%	-
Receivables	70.12	58.61	42.35	28.01	11.3	2.23
Inventory	42.9	32.58	21.05	10.6	3.95	1.09
Other Current Assets	6.48	5.31	5.69	2.47	0.13	0.76
Total Current Assets	235.56	422.91	245.2	205.67	39.41	25.96
Property, Plant & Equipment	69.34	72.36	61.38	7.5	3.33	0.92
Long-Term Investments	0	0	3.98	0	0	0
Goodwill and Intangibles	365.22	0	0	0	0	0
Other Long-Term Assets	4.12	8.89	0.98	0.92	1.81	0.02
Total Long-Term Assets	438.67	81.25	66.34	8.42	5.14	0.94
Total Assets	674.24	504.15	311.54	214.09	44.55	26.9
Accounts Payable	10.58	7.66	6.54	3.05	2.55	0.71
Current Debt	1.69	1.31	0.8	0	0	0
Other Current Liabilities	64.07	47.2	35.17	10.79	6.32	1.41
Total Current Liabilities	76.34	56.17	42.51	13.84	8.87	2.13
Long-Term Debt	30.36	30.98	28.4	0	19.48	9.84
Other Long-Term Liabilities	102.63	0	1.42	0	1.17	0.21
Total Long-Term Liabilities	132.99	30.98	29.82	0	20.65	10.05
Total Liabilities	209.33	87.15	72.33	13.84	29.52	12.18
Total Debt	32.05	32.29	29.21	0	19.48	9.84
Debt Growth	-0.74%	10.55%	-	-	98.05%	-
Retained Earnings	-48.49	-46.85	-17.58	-27.42	-41.21	-40.12
Comprehensive Income	8.89	0.85	-0.4	0	0	0
Shareholders' Equity	464.91	417	239.21	200.25	-39.14	-39.45
Net Cash / Debt	84.02	294.11	146.89	164.6	4.55	12.05
Net Cash / Debt Growth	-71.43%	100.22%	-10.76%	3520.72%	-62.27%	-
Net Cash Per Share	1.48	5.57	2.64	3.19	0.77	2.38
Working Capital	159.22	366.73	202.69	191.84	30.54	23.84
Book Value Per Share	8.19	7.89	4.80	6.25	-6.65	-7.80

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).